IDEXX LABORATORIES INC /DE Secured Debt, Current
IDEXX LABORATORIES INC /DE (IDXX) had Secured Debt, Current of $1.05 million as of 2014-03-31, per its 10-Q filed 2014-04-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:SecuredDebtCurrent · last filed 2015-02-17
- 2014-03-31: Secured Debt, Current $1.05M.
- 2013-12-31: Secured Debt, Current $1.03M.
- 2013-09-30: Secured Debt, Current $1.02M.
- 2013-06-30: Secured Debt, Current $1.14M.
| Period end | Secured Debt, Current |
|---|---|
| 2014-03-31 | $1.05M 10-Q · filed 2014-04-25 |
| 2013-12-31 | $1.03M 10-K · filed 2015-02-17 |
| 2013-09-30 | $1.02M 10-Q · filed 2013-10-22 |
| 2013-06-30 | $1.14M 10-Q · filed 2013-07-23 |
| 2013-03-31 | $1.12M 10-Q · filed 2013-04-23 |
| 2012-12-31 | $1.11M 10-K · filed 2014-02-18 |
| 2012-09-30 | $960.00K 10-Q · filed 2012-10-19 |
| 2012-06-30 | $945.00K 10-Q · filed 2012-07-20 |
| 2012-03-31 | $931.00K 10-Q · filed 2012-04-20 |
| 2011-12-31 | $917.00K 10-K · filed 2013-02-19 |
| 2011-09-30 | $903.00K 10-Q · filed 2011-10-21 |
| 2011-06-30 | $890.00K 10-Q · filed 2011-07-22 |
| 2011-03-31 | $877.00K 10-Q · filed 2011-04-21 |
| 2010-12-31 | $863.00K 10-K · filed 2012-02-17 |
| 2010-09-30 | $850.00K 10-Q · filed 2010-10-22 |
| 2010-06-30 | $838.00K 10-Q · filed 2010-07-23 |
| 2009-12-31 | $813.00K 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |